Canadian Rheumatology Association Annual Meeting
Whistler, BC—An observational study confirms in a real-world setting that people with rheumatoid arthritis (RA) who have low disease activity (LDA) after 6 months of biologic treatment are very likely to achieve remission within the next 6 months.
Ottawa, Ontario—A simple questionnaire can help clinicians track adverse events (AEs) and plan medication adjustments in patients receiving biologic drug therapy, according to researchers at The Hospital for Sick Children in Toronto, Ontario, who presented at the recent Canadian Rheumatology Association annual meeting.
By Rosemary Frei, MSc
- 1
- 2
Page 2 of 2
Results 11 - 12 of 12
Results 11 - 12 of 12